Journal of Ophthalmology / 2014 / Article / Tab 4 / Clinical Study
Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma Table 4 Literature review of 13 choroidal new vessels associated with choroidal osteomas treated with intravitreal anti-VEGF injections
.
Author Age Gender Osteoma location & longest dimension CNV location Initial vision Final vision Initial CFT (microns) Final CFT (microns) Type & number of injections Follow-up (month)
Ahmadieh and Vafi [18 ] 19 F Juxtafoveal 3DD OD Juxtafoveal 6/60 6/7.5 544 240 One 1.25 mg bevacizumab 9 (regression of CNV) Narayanan and Shah [19 ] 25 F Peripapillary OS Subfoveal CF 1.5 m 6/35 NM NM Two 1.25 mg bevacizumab 4 (regression of CNV) Shields et al. [20 ] 34 F Subfoveal 7DD OD Subfoveal 6/30 6/9 NM NM One 1.25 mg bevacizumab & three 0.5 mg ranibizumab 6 (fibrotic CNV with flat macula) Song et al. [21 ] 24 M Peripapillary 2.5DD Juxtafoveal CF 20 cm 6/60 NM NM Two 1.25 mg bevacizumab 10; prior to PDT Song and Roh [22 ] 43 F Subfoveal 4DD OS Subfoveal 6/60 6/30 NM NM One 0.5 mg ranibizumab 6 (regression of CNV) Rao and Gentile [23 ] 24 M Subfoveal 2DD OS Subfoveal 6/18 6/9 NM NM Three 1.25 mg bevacizumab 5 Ayachit et al. [24 ] 27 F Peripapillary 3DD OD Juxtafoveal 6/7.5 6/6 NM NM One bevacizumab (dose NM) 6 (regression of CNV) Kubota-Taniai et al. [25 ] 12 F Peripapillary 3DD OS Extrafoveal 6/30 6/9 NM NM Two 1.25 mg bevacizumab 48 (regression of CNV) Salehipour et al. [26 ] 19 F NM NM NM NM NM NM Two 1.25 mg bevacizumab 7
Wu et al. [27 ] 46 F Subfoveal OS Subfoveal 6/30 6/12 NM 116 micron flattening Two 1.25 mg bevacizumab 23 Wu et al. [27 ] 57 F Peripapillary 10DD OD Subfoveal 6/240 6/9 NM NM Three 0.5 mg ranibizumab 14 (fibrosis of CNV) Carle et al. [28 ] 20 M Macular OD Occult 6/24 6/12 NM NM Six 1.25 mg bevacizumab 13 Erol et al. [29 ] 28 F Peripapillary and macular 4DD OD Subfoveal 6/120 6/24 after first injection and then 6/60 after second injection NM NM Two 0.5 mg ranibizumab 2 (Tear of the retinal pigment epithelium after ranibizumab injection)
VEGF = vascular endothelial growth factor; CNV = choroidal neovascularization; CFT = central foveal thickness in microns; DD = disc diameter; NM = not mentioned; OD = right eye; OS = left eye; M = male; F = female; PDT = photodynamic therapy.